The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R.; Pluzanska, A.; Tomiak, E.; Koopmanschap, M.; Piccart, M.

期刊名称European Journal of Cancer
作者Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R.; Pluzanska, A.; Tomiak, E.; Koopmanschap, M.; Piccart, M.
卷第35卷
印刷ISSN0959-8049
文件大小131.89KB
发表时间1999-9
DOI10.1016/S0959-8049(99)81671-2

发现好书期刊，享受阅读乐趣